Återköp i AstraZeneca 25 april 2012 till 3 maj 2012

Report this content

 

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 313,590 ordinary shares of AstraZeneca PLC at a price of 2710 pence per share on 2 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,269,470,811.

A C N Kemp

Company Secretary

3 May 2012

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 312,437 ordinary shares of AstraZeneca PLC at a price of 2721 pence per share on 1 May 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,269,732,897.

A C N Kemp

Company Secretary

2 May 2012

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 314,670 ordinary shares of AstraZeneca PLC at a price of 2700 pence per share on 30 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,270,014,020.

A C N Kemp

Company Secretary

1 May 2012

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 318,283 ordinary shares of AstraZeneca PLC at a price of 2666 pence per share on 27 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,270,277,361.

A C N Kemp

Company Secretary

30 April 2012

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 316,066 ordinary shares of AstraZeneca PLC at a price of 2686 pence per share on 26 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,270,501,025.

A C N Kemp

Company Secretary

27 April 2012

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 300,591 ordinary shares of AstraZeneca PLC at a price of 2831 pence per share on 25 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,270,729,222.

A C N Kemp

Company Secretary

26 April 2012


REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 300,636 ordinary shares of AstraZeneca PLC at a price of 2831 pence per share on 24 April 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,270,972,238.

A C N Kemp

Company Secretary

25 April 2012

 

 

Tags:

Subscribe